About This Tool

The Antipsychotic Dose Equivalency Calculator provides an estimated equivalent dose when switching from one antipsychotic medication to another. The calculations are based on the concept of chlorpromazine (CPZ) 100mg equivalents, a widely used method for standardizing antipsychotic potency. This tool is intended for educational and informational purposes only and should never replace professional clinical judgment.

Outputs Explained

After you input the source drug and dose, the calculator provides the following key outputs:

• Equivalent Daily Dose: The estimated dose of the target medication in milligrams (mg) per day that is theoretically equivalent to the source dose.
• Therapeutic Range Comparison: The calculated dose is compared against the typical therapeutic oral dose range of the target drug. A flag will indicate if the equivalent dose is BELOW, WITHIN, or ABOVE this standard range.
• Clinical Notes: Important context-specific warnings may be displayed. For instance, special considerations for clozapine (due to its unique profile and risks) or partial agonists (like aripiprazole) are highlighted, as direct equivalency calculations may be less reliable for these agents.

How to Use the Calculator

1. Select Source Drug: Choose the patient’s current antipsychotic medication from the first dropdown list.
2. Select Target Drug: Choose the medication you are considering switching to from the second dropdown list.
3. Choose Formulation: Select “Oral” or a specific Long-Acting Injectable (LAI) formulation if available for the source drug.
4. Enter Source Dose: If “Oral” is selected, enter the current total daily dose in milligrams. This field is hidden for LAIs as the dose is pre-defined.
5. Calculate: Click the “Calculate Equivalency” button to see the results.

Dosing Overview

Antipsychotic dose equivalency is a method to compare the potencies of different antipsychotic drugs. The most common reference point is chlorpromazine. For example, if haloperidol has a CPZ 100mg equivalent of 2mg, it means 2mg of haloperidol has a similar D2 receptor blocking effect as 100mg of chlorpromazine.

This tool uses these established equivalency factors to convert a dose of one drug to another. It handles both oral daily doses and converts long-acting injectable (LAI) doses into an average daily dose (e.g., 300 mg every 4 weeks is converted to an average of 10.7 mg/day) before calculating the equivalency.

Switching Antipsychotics

Switching antipsychotics is a complex clinical decision that requires careful planning and monitoring. This tool’s dose equivalency calculation is only the first step. Clinicians must consider several strategies for the switch, such as:

• Cross-tapering: Gradually decreasing the dose of the first medication while simultaneously increasing the dose of the new one. This is often the safest approach.
• Immediate switch: Stopping the first drug and starting the new one at an equivalent dose. This carries a higher risk of relapse or side effects.
• Pharmacokinetic properties: Consider the half-lives of both drugs. A drug with a long half-life may provide some “self-tapering.”

Always monitor the patient for withdrawal symptoms from the first drug, side effects from the new drug, and re-emergence of psychotic symptoms.

Managing a Missed Dose

The management of a missed dose depends on the specific medication, its half-life, and how much time has passed since the dose was due.

• Oral Medications: For most daily oral antipsychotics, if only a few hours have passed, the patient can take the dose as soon as they remember. If it is almost time for the next scheduled dose, they should skip the missed dose and resume their normal schedule. They should not take a double dose.
• Long-Acting Injectables (LAIs): Missing a scheduled injection requires more careful management. Each LAI has a specific window for administration and may have a re-initiation protocol if that window is missed. Consult the drug’s official prescribing information for guidance on delayed or missed injections.

Safety Alerts

• Not a Substitute for Clinical Judgment: All calculations are estimates. Patient-specific factors (age, genetics, comorbidities, concomitant medications) can significantly alter clinical response.
• Black Box Warning: All antipsychotics carry a black box warning regarding increased mortality in elderly patients with dementia-related psychosis.
• Clozapine: Switching to or from clozapine is particularly complex and should only be done by experienced prescribers. Its dose equivalency is not well-established, and it has significant risks, including severe neutropenia (agranulocytosis), requiring strict blood monitoring.
• Partial Agonists: Drugs like aripiprazole, brexpiprazole, and cariprazine have a different mechanism of action (D2 partial agonism) than most other antipsychotics. This can make dose equivalency conversions less predictable.

Frequently Asked Questions (FAQ)

What does “CPZ 100mg equivalent” mean?

It is a standardized measure of an antipsychotic’s potency relative to 100 mg of chlorpromazine. A lower CPZ equivalent value indicates a higher potency drug (i.e., fewer milligrams are needed for a similar effect).

Why are the calculated doses just estimates?

Dose equivalency tables are derived from various sources, including clinical studies and receptor binding affinities, but there is no single universally accepted standard. Individual patient response can vary greatly.

Does this calculator work for long-acting injectables (LAIs)?

Yes. For certain source drugs, you can select a specific LAI formulation. The tool converts the LAI dose and its administration interval (e.g., 400 mg every 4 weeks) into an average daily oral equivalent dose before performing the calculation.

What is the clinical significance of the “partial-agonist” note?

Partial agonists (like aripiprazole) do not fully block dopamine D2 receptors; they modulate them. When switching from a full antagonist, this can lead to unpredictable effects. The switch requires careful monitoring.

Why is there a special warning for clozapine?

Clozapine has a unique efficacy and side effect profile, including the risk of life-threatening agranulocytosis. Its dosing is highly individualized and based on slow titration and clinical response, not on simple equivalency calculations.

What should I do if the calculated dose is “Above” or “Below” the typical range?

This flag is a clinical alert. A dose below the therapeutic range may be ineffective, while a dose above it may increase the risk of side effects. It suggests that the switch requires careful clinical consideration and may necessitate starting at a lower dose and titrating, or that the switch may not be appropriate.

Can I use this tool for a patient on two antipsychotics (polypharmacy)?

No. The calculator is designed for a one-to-one switch. Converting from polypharmacy is a highly complex scenario that is outside the scope of this tool.

Are the therapeutic ranges shown applicable to all conditions (e.g., schizophrenia vs. bipolar disorder)?

The ranges provided are generally for the treatment of psychosis in adults. Dosing for other indications, or for pediatric or geriatric populations, may differ. Always consult the official prescribing information for indication-specific dosing.

References

1. Leucht S, Samara M, Heres S, et al. Dose Equivalents for Antipsychotic Drugs: The DDD versus the Chlorpromazine Equivalent. Pharmacopsychiatry. 2015;49(01):12-17. View Abstract
2. Gardner DM, Murphy AL, O’Donnell H, Centorrino F, Baldessarini RJ. International consensus study of antipsychotic dosing. Am J Psychiatry. 2010;167(6):686-693. View on PubMed
3. National Institute for Health and Care Excellence (NICE). Psychosis and schizophrenia in adults: prevention and management (CG178). nice.org.uk
4. U.S. Food and Drug Administration (FDA). Drugs@FDA Database. accessdata.fda.gov
5. European Medicines Agency (EMA). Medicines Database. ema.europa.eu